Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Rheumatol

Retrieve available abstracts of 166 articles:
HTML format
Text format



Single Articles


    June 2017
  1. AYDIN SZ, Gunal EK, Ozata M, Keskin H, et al
    Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  2. LEON L, Gomez A, Vadillo C, Pato E, et al
    Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  3. BELL DA, Elhayek S, Cairns E, Barra L, et al
    Anti-homocitrullinated protein antibody isotype usage in rheumatoid arthritis and their unaffected first-degree relatives.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  4. MARRIE RA, Hitchon CA, Peschken CA, Chen H, et al
    Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  5. MASI AT, Rehman AA, Jorgenson LC, Aldag JC, et al
    Preclinical biomarker associations with both incident rheumatoid arthritis and its subsequent mortality: sex effects in a 41-year, community-based, case-control cohort study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  6. LESUIS N, van Vollenhoven RF, Akkermans RP, Verhoef LM, et al
    Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    May 2017
  7. HAMMER HB, Kvien TK, Terslev L
    Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  8. DUQUENNE C, Wendling D, Sibilia J, Job-Deslandre C, et al
    Glucocorticoid-sparing effect of first-year anti-TNFalpha treatment in rheumatoid arthritis (CORPUS Cohort).
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  9. CAPORALI R, Idolazzi L, Bombardieri S, Ferraccioli G, et al
    Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  10. SEBASTIANI M, Manfredi A, Cassone G, Sandri G, et al
    Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  11. ACEBES C, Andreu JL, Balsa A, Battle E, et al
    Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  12. CODULLO V, Iannone F, Sinigaglia L, Favalli EG, et al
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  13. GULLICK NJ, Mian AN, Ibrahim F, Walker D, et al
    Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  14. RASHID T, Ebringer A, Wilson C
    The link between Proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  15. GADEHOLT O
    Rheumatoid arthritis is not a single disease.
    Clin Exp Rheumatol. 2017;35 Suppl 104:20-21.
    PubMed     Text format     Abstract available


  16. ANGELOTTI F, Parma A, Cafaro G, Capecchi R, et al
    One year in review 2017: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35:368-378.
    PubMed     Text format     Abstract available


    April 2017
  17. HARAOUI B, Casado G, Czirjak L, Taylor A, et al
    Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  18. FUKUYO S, Nakayamada S, Iwata S, Kubo S, et al
    Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    March 2017
  19. TIEN YC, Yen HH, Chiu YM
    Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  20. KURIYA B, Schieir O, Lin D, Xiong J, et al
    Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  21. YANG M, Galebach PJ, Signorovitch JE, Garg V, et al
    Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  22. AVILA-RIBEIRO P, Brault Y, Dougados M, Gossec L, et al
    Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  23. CAPORALI R, Carletto A, Conti F, D'Angelo S, et al
    Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  24. FERRO F, Marcucci E, Orlandi M, Baldini C, et al
    One year in review 2017: primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:179-191.
    PubMed     Text format     Abstract available


  25. PERTOVAARA M, Parkkila S, Korpela M
    Anti-carbonic anhydrase autoantibodies and serum beta-2 microglobulin correlate with the ClinESSDAI score in patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:351.
    PubMed     Text format     Abstract available


  26. ARENDS S, Meiners PM, Moerman RV, Kroese FG, et al
    Physical fatigue characterises patient experience of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:255-261.
    PubMed     Text format     Abstract available


  27. HAACKE EA, van der Vegt B, Meiners PM, Vissink A, et al
    Abatacept treatment of patients with primary Sjogren's syndrome results in a decrease of germinal centres in salivary gland tissue.
    Clin Exp Rheumatol. 2017;35:317-320.
    PubMed     Text format     Abstract available


  28. LEE KE, Kang JH, Yim YR, Kim JE, et al
    Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:234-240.
    PubMed     Text format     Abstract available


  29. GIUFFRA V, Minozzi S, Vitiello A, Fornaciari A, et al
    On the history of gout: paleopathological evidence from the Medici family of Florence.
    Clin Exp Rheumatol. 2017;35:321-326.
    PubMed     Text format     Abstract available


    February 2017
  30. CURTIS JR, Lee EB, Martin G, Mariette X, et al
    Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  31. KIM HW, Kwon YJ, Park BW, Song JJ, et al
    Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  32. GANDIGA PC, George MD, Baker JF
    Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNF.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  33. PERROT S, Peixoto M, Dieude P, Hachulla E, et al
    Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR1990 and revised ACR 2010 criteria.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    January 2017
  34. NIKIPHOROU E, Galloway J, van Riel P, Yazici Y, et al
    The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  35. LENERT A, Fardo DW
    Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  36. NAGAFUCHI Y, Shoda H, Sumitomo S, Nakachi S, et al
    Enhanced gut homing receptor expression of unswitched memory B cells in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  37. BAKER JF, Ostergaard M, Emery P, Baker DG, et al
    Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  38. ADDIMANDA O, Marino M, Farina I, Trevisani M, et al
    Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  39. LAMPROPOULOS CE, Orfanos P, Manoussakis MN, Tzioufas AG, et al
    Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  40. AYDIN SZ, Pay S, Inanc N, Kamali S, et al
    Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  41. AMANN J, Wessels AM, Breitenfeldt F, Huscher D, et al
    Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  42. L'AMI MJ, Kneepkens EL, Nurmohamed MT, Krieckaert CL, et al
    Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  43. PARK SK, Lee MY, Jang EJ, Kim HL, et al
    A comparison of discontinuation rates of tofacitinib and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  44. KRUMBHOLZ G, Junker S, Meier FM, Rickert M, et al
    Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  45. HU Y, Cui J, Sparks JA, Malspeis S, et al
    Circulating carotenoids and subsequent risk of rheumatoid arthritis in women.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  46. TOURNADRE A, Pereira B, Dubost JJ, Rincheval N, et al
    Management of dyslipidemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  47. CURTIS JR, Schulze-Koops H, Takiya L, Mebus CA, et al
    Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  48. NICAISE C, Weichselbaum L, Schandene L, Gangji V, et al
    Phagocyte-specific S100A8/A9 is upregulated in primary Sjogren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Clin Exp Rheumatol. 2017;35:129-136.
    PubMed     Text format     Abstract available


  49. BIRT JA, Tan Y, Mozaffarian N
    Sjogren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.
    Clin Exp Rheumatol. 2017;35:98-107.
    PubMed     Text format     Abstract available


  50. ATZENI F, Gianturco L, Colombo C, Ricci C, et al
    Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjogren's syndrome?
    Clin Exp Rheumatol. 2017;35:173.
    PubMed     Text format     Abstract available


    December 2016
  51. CALVO-ALEN J, Monteagudo I, Salvador G, Vazquez-Rodriguez TR, et al
    Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  52. KRAUSE C, Herborn G, Braun J, Rudolf H, et al
    Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  53. CECCARELLI F, Massafra U, Perricone C, Idolazzi L, et al
    Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE).
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  54. MARTELLI-PALOMINO G, Paoliello-Paschoalato AB, Crispim JC, Rassi DM, et al
    DNA damage increase in peripheral neutrophils from patients with rheumatoid arthritis is associated with the disease activity and the presence of shared epitope.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  55. DETORAKIS EE, Magkanas E, Lasithiotaki I, Sidiropoulos P, et al
    Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-alpha agents.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  56. GIOLLO A, Viapiana O, Carletto A, Ortolani R, et al
    Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  57. URSINI F, D'Angelo S, Russo E, Arturi F, et al
    Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  58. MASI AT, Rehman AA, Jorgenson LC, Aldag JC, et al
    Increased mortality of incident rheumatoid arthritis (RA) versus matched non-RA control subjects: a community-based long-term prospective cohort study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  59. RODRIGUEZ-RODRIGUEZ L, Leon L, Ivorra-Cortes J, Gomez A, et al
    Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  60. GENTY M, Combe B, Kostine M, Ardouin E, et al
    Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relation with sleep disorders, depression and clinical efficacy. A prospective, multicentre study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  61. RAMIREZ J, Iniciarte-Mundo J, Cuervo A, Ruiz-Esquide V, et al
    Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  62. CUPPEN BV, Jacobs JW, Ter Borg EJ, Marijnissen AC, et al
    Necessity of TNF-alpha inhibitor discontinuation in rheumatoid arthritis is predicted by smoking and number of previously used biological DMARDs.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  63. BOUBOUCHAIROPOULOU N, Flouri I, Drosos AA, Boki K, et al
    Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  64. CECCHETTI S, Tatar Z, Galan P, Pereira B, et al
    Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  65. HAMURYUDAN V, Direskeneli H, Ertenli I, Inanc M, et al
    Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  66. FISHER BA, Donatien P, Filer A, Winlove CP, et al
    Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  67. JIANG M, Ren F, Zheng Y, Yan R, et al
    Efficacy and safety of down-titration versus continuation strategies of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis with low disease activity or in remission: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  68. BELLUCCI E, Terenzi R, La Paglia GM, Gentileschi S, et al
    One year in review 2016: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34:793-801.
    PubMed     Text format     Abstract available


  69. BERGSTRA SA, Machado PM, van den Berg R, Landewe RB, et al
    Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectives.
    Clin Exp Rheumatol. 2016;34 Suppl 101:87-90.
    PubMed     Text format     Abstract available


  70. HETLAND ML, Krogh NS, Horslev-Petersen K, Schiottz-Christensen B, et al
    Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry.
    Clin Exp Rheumatol. 2016;34 Suppl 101:75-78.
    PubMed     Text format     Abstract available


  71. JACOBS JW
    The Computer Assisted Management in Early Rheumatoid Arthritis programme tool used in the CAMERA-I and CAMERA-II studies.
    Clin Exp Rheumatol. 2016;34 Suppl 101:69-72.
    PubMed     Text format     Abstract available


  72. VAN RIEL PL, Renskers L
    The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34 Suppl 101:40-44.
    PubMed     Text format     Abstract available


  73. SCHEINBERG M
    Is Etanar a new biologic?
    Clin Exp Rheumatol. 2016;34:954.
    PubMed     Text format     Abstract available


  74. HILLEN MR, Moret FM, Giovannone B, Kruize AA, et al
    Size matters: decreased glandular levels of anti-inflammatory short thymic stromal lymphopoietin in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:959-960.
    PubMed     Text format     Abstract available


  75. LAZAROU I, Kelly S, Humby F, Di Cicco M, et al
    Ultrasound-guided synovial biopsy of the wrist does not alter subsequent clinical or ultrasound disease activity assessments: a prospective study for incorporation of imaging in clinical trials.
    Clin Exp Rheumatol. 2016;34:802-807.
    PubMed     Text format     Abstract available


  76. SOLFIETTI L, Binello GB, Stella S, Bazzan M, et al
    Thrombin generation assay: interactions between chronic inflammation and haemostasis in patients with autoimmune diseases.
    Clin Exp Rheumatol. 2016;34:925-928.
    PubMed     Text format     Abstract available


  77. PINCUS T
    Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  78. RICHTER A, Meissner Y, Strangfeld A, Zink A, et al
    Primary and secondary patient data in contrast: the use of observational studies like RABBIT.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  79. PINCUS T
    Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  80. ALETAHA D, Becede M, Smolen JS
    Information technology concerning SDAI and CDAI.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  81. HUO Y, Veldhuizen RD, van der Heijde DM, Besselink NJ, et al
    Automated joint space width quantification of hand and wrist joints: a proof of concept study.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  82. LEEB BF, Brezinschek HP, Rintelen B
    RADAI-5 and electronic monitoring tools.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  83. SONG ST, Kim JJ, Lee S, Kim HA, et al
    Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


    August 2016
  84. LEVITSKY A, Wick MC, Mottonen T, Leirisalo-Repo M, et al
    Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  85. KUBO S, Nakano K, Nakayamada S, Hirata S, et al
    Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  86. FERRAZ-AMARO I, Lopez-Mejias R, Ubilla B, Genre F, et al
    Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  87. KUUSALO LA, Puolakka KT, Kautiainen H, Alasaarela EM, et al
    Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  88. VAN DEN HOEK J, Roorda LD, Boshuizen HC, Tijhuis GJ, et al
    Trend in and predictors for cardiovascular mortality in patients with rheumatoid arthritis over a period of 15 years: a prospective cohort study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  89. YOSHIHARA H, Yoneoka D, Margalit A
    National trends and in-hospital outcomes in patients with rheumatoid arthritis undergoing elective atlantoaxial spinal fusion surgery.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  90. ASAMI Y, Ishiguro H, Ueda A, Nakajima H, et al
    First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  91. VASSILOPOULOS D, Delicha EM, Settas L, Andrianakos A, et al
    Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  92. MILUTINOVIC S
    Reply to: Could this be the pioneering case of short-blanket syndrome? Filippou et al.
    Clin Exp Rheumatol. 2016;34:721.
    PubMed     Text format    


  93. FILIPPOU G, Bertoldi I, Frediani B
    Could this be the pioneering case of short-blanket syndrome? Comment on: Development of ultrasound enthesitis score to identify patients with enthesitis having spondyloarthritis: prospective, double-blinded, controlled study. Milutinovic et al. Clin E
    Clin Exp Rheumatol. 2016;34:721.
    PubMed     Text format    


  94. TYRSIN D, Chuvpilo S, Matskevich A, Nemenov D, et al
    From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  95. AVCI AB, Feist E, Burmester GR
    Targeting GM-CSF in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  96. PALM O, Ueland T, Garen T, Michelsen AE, et al
    Endostatin is higher and associated with pulmonary involvement in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:690-3.
    PubMed     Text format     Abstract available


  97. VREJU FA, Filippucci E, Gutierrez M, Di Geso L, et al
    Subclinical ultrasound synovitis in a particular joint is associated with ultrasound evidence of bone erosions in that same joint in rheumatoid patients in clinical remission.
    Clin Exp Rheumatol. 2016;34:673-8.
    PubMed     Text format     Abstract available


  98. CAPALDO C, Carvajal Alegria G, Cornec D, Jousse-Joulin S, et al
    The active immunological profile in patients with primary Sjogren's syndrome is restricted to typically encountered autoantibodies.
    Clin Exp Rheumatol. 2016;34:722.
    PubMed     Text format    


  99. ASIKAINEN J, Nikiphorou E, Kaarela K, Lindqvist E, et al
    Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-up.
    Clin Exp Rheumatol. 2016;34:641-5.
    PubMed     Text format     Abstract available


  100. LEE J, Koh JH, Kwok SK, Park SH, et al
    The EULAR Sjogren's Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:663-7.
    PubMed     Text format     Abstract available


  101. BARONE F, Colafrancesco S
    Sjogren's syndrome: from pathogenesis to novel therapeutic targets.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


    June 2016
  102. DETERT J, Dziurla R, Hoff P, Gaber T, et al
    Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  103. FRITSCH-STORK RD, Silva-Cardoso SC, Groot Koerkamp MJ, Broen JC, et al
    Expression of ERAP2 and LST1 is increased before start of therapy in rheumatoid arthritis patients with good clinical response to glucocorticoids.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  104. CHE H, Combe B, Morel J, Cantagrel A, et al
    Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  105. KAWASHIRI SY, Nishino A, Suzuki T, Nakashima Y, et al
    Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practi
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  106. PLASENCIA C, Wolbink G, Krieckaert CL, Kneepkens EL, et al
    Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  107. RODRIGUEZ-RODRIGUEZ L, Leon L, Lamas JR, Gomez A, et al
    Dose down-titration of biological DMARDs in patients with rheumatoid arthritis over time and in daily clinical practice.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  108. AALTONEN KJ, Turunen JH, Sokka T, Puolakka K, et al
    A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  109. WANG T, Zheng XJ, Ji YL, Liang ZA, et al
    Tumour markers in rheumatoid arthritis-associated interstitial lung disease.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  110. BAGNATO GL, Fiorenza A, Cordova F, Roberts WN, et al
    Clinical, autoimmune, and psychiatric parameters correlate with sleep disturbance in patients with systemic sclerosis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  111. HOLDEN SE, Currie CJ, Lennon M, Reynolds AV, et al
    Cost of dose escalation in people with rheumatoid arthritis treated with TNF inhibitors across Europe.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  112. CALABRO A, Caterino AL, Elefante E, Valentini V, et al
    One year in review 2016: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34:357-72.
    PubMed     Text format     Abstract available


  113. PRIORI R, Minniti A, Antonazzo B, Fusconi M, et al
    Sleep quality in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:373-9.
    PubMed     Text format     Abstract available


  114. VASKO R, Streich JH, Blaschke S, Muller GA, et al
    Vimentin fragments are potential markers of rheumatoid synovial fibroblasts.
    Clin Exp Rheumatol. 2016;34:513-20.
    PubMed     Text format     Abstract available


  115. PERTOVAARA M, Korpela M
    Regular physical activity is associated with lower levels of ESSPRI and other favourable patient-reported outcomes in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:560.
    PubMed     Text format    


  116. ZABOTTI A, Salvin S, Quartuccio L, De Vita S, et al
    Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands.
    Clin Exp Rheumatol. 2016;34:459-65.
    PubMed     Text format     Abstract available


  117. SAKAIRI T, Hiromura K, Kaneko Y, Maeshima A, et al
    Histological findings in the spleen affected by adult-onset Still's disease: a report of three cases.
    Clin Exp Rheumatol. 2016;34:566-7.
    PubMed     Text format    


    April 2016
  118. RAYMOND AR, Brooksbank RL, Millen AM, Norton GR, et al
    Telomere length, endothelial activation and carotid atherosclerosis in black and white African patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  119. WALLENSTEIN GV, Kanik KS, Wilkinson B, Cohen S, et al
    Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  120. KREMER JM, Blanco R, Halland AM, Brzosko M, et al
    Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  121. GUALTIEROTTI R, Ingegnoli F, Griffini S, Grovetti E, et al
    Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  122. GONZALEZ-FERNANDEZ ML, Valor L, Morales-Lozano R, Hernandez-Florez D, et al
    To what extent is foot pain related to biomechanical changes and ultrasound-detected abnormalities in rheumatoid arthritis?
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  123. HOLMSTROM M, Koivuniemi R, Korpi K, Kaasalainen T, et al
    Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  124. GENG Y, Han J, Deng X, Zhang Z, et al
    Deep clinical remission: an optimised target in the management of rheumatoid arthritis? Experience from an ultrasonography study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  125. YANG X, Wang M, Zhang X, Li X, et al
    Diagnostic accuracy of anti-RA33 antibody for rheumatoid arthritis: systematic review and meta-analysis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  126. LEE YH, Bae SC
    Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  127. MANARA M, Bianchi G, Bruschi E, Azzolini V, et al
    Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: results from the MARI study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  128. RONGEN-VAN DARTEL SA, Repping-Wuts H, Donders R, van Hoogmoed D, et al
    A multidimensional 'path analysis' model of factors explaining fatigue in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  129. NUSSLEIN HG, Alten R, Galeazzi M, Lorenz HM, et al
    Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  130. HODGE JA, Kawabata TT, Krishnaswami S, Clark JD, et al
    The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  131. SARAUX A, Rouanet S, Flipo RM, Poncet JC, et al
    Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  132. RUIZ-LARRANAGA O, Uribarri M, Alcaro MC, Escorza-Trevino S, et al
    Genetic variants associated with rheumatoid arthritis patients and serotypes in European populations.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  133. LOPALCO G, Vitale A, Iannone F, Cantarini L, et al
    Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection.
    Clin Exp Rheumatol. 2016;34:353.
    PubMed     Text format    


  134. CHOI BY, Oh HJ, Lee YJ, Song YW, et al
    Prevalence and clinical impact of fibromyalgia in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  135. FERRO F, Vagelli R, Bruni C, Cafaro G, et al
    One year in review 2016: Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:161-71.
    PubMed     Text format     Abstract available


  136. GALICIA-HERNANDEZ G, Parra-Salcedo F, Ugarte-Martinez P, Contreras-Yanez I, et al
    Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era.
    Clin Exp Rheumatol. 2016;34:261-9.
    PubMed     Text format     Abstract available


  137. MAUERMANN M, Hochauf-Stange K, Kleymann A, Conrad K, et al
    Parvovirus infection in early arthritis.
    Clin Exp Rheumatol. 2016;34:207-13.
    PubMed     Text format     Abstract available


  138. QUARTUCCIO L, Salvin S, Corazza L, Gandolfo S, et al
    Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjogren's syndrome: follow-up after the end of the phase II open-label BELISS study.
    Clin Exp Rheumatol. 2016;34:311-4.
    PubMed     Text format     Abstract available


  139. YOKOGAWA N, Lieberman SM, Sherry DD, Vivino FB, et al
    Features of childhood Sjogren's syndrome in comparison to adult Sjogren's syndrome: considerations in establishing child-specific diagnostic criteria.
    Clin Exp Rheumatol. 2016;34:343-51.
    PubMed     Text format     Abstract available


    February 2016
  140. TEJERA-SEGURA B, de Vera-Gonzalez AM, Lopez-Mejias R, Gonzalez-Gay MA, et al
    Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  141. SEBASTIANI M, Manfredi A, Cerri S, Della Casa G, et al
    Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  142. YOSHIHARA H, Yoneoka D, Margalit A, Zuckerman JD, et al
    Rheumatoid arthritis patients undergoing total hip and knee arthroplasty have better in-hospital outcomes compared with non-rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  143. BERTHELOT JM, Sibilia J
    Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  144. RINALDI LA, Simoni D, Maresca M, Monaco V, et al
    Gait abnormalities in early rheumatoid arthritis with temporomandibular joint involvement.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  145. IANNONE F, Tampoia M, Giannini M, Lopalco G, et al
    Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  146. REMUZGO-MARTINEZ S, Genre F, Lopez-Mejias R, Ubilla B, et al
    Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  147. SCOTT IC, Ibrahim F, Simpson G, Kowalczyk A, et al
    A randomised trial evaluating anakinra in early active rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  148. FRAGOULIS GE, Stamopoulos P, Barbatis C, Tzioufas AG, et al
    Panniculitis: an unusual presenting manifestation of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  149. NAREDO E, Iagnocco A
    One year in review: ultrasound in arthritis.
    Clin Exp Rheumatol. 2016;34:1-10.
    PubMed     Text format     Abstract available


  150. VALIM V, Gerdts E, Jonsson R, Ferreira GA, et al
    Atherosclerosis in Sjogren's syndrome: evidence, possible mechanisms and knowledge gaps.
    Clin Exp Rheumatol. 2016;34:133-42.
    PubMed     Text format     Abstract available


  151. GUGGINO G, Ciccia F, Raimondo S, Giardina G, et al
    Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:25-31.
    PubMed     Text format     Abstract available


    December 2015
  152. COLOMBO E, Scarsi M, Piantoni S, Tincani A, et al
    Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  153. VIZZARDI E, Bazzani C, Cavazzana I, Sciatti E, et al
    Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  154. COHEN SB, Koenig A, Wang L, Kwok K, et al
    Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  155. ANECCHINO C, Fanizza C, Marino V, Romero M, et al
    Drug outcome survey to evaluate anti-TNF treatment in rheumatoid arthritis: an Italian observational study (the DOSE study).
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  156. INANC N, Ozen G, Direskeneli H
    Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-alpha inhibitor treatment in rheumatoid arthritis: a prospective cohort study.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  157. FEDELE AL, Alivernini S, Gremese E, Ferraccioli G, et al
    CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  158. BARBIERI F, Zampogna G, Camellino D, Paparo F, et al
    Ankylosis of the wrist bones in patients with rheumatoid arthritis: a study with extremity-dedicated MRI.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  159. CHEUNG PP, Guo Y, Lahiri M
    Predominance of large joint active synovitis in Asian patients with established rheumatoid arthritis.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  160. YANG X, Gao F, Liu Y
    Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis.
    Clin Exp Rheumatol. 2015;33:900-3.
    PubMed     Text format     Abstract available


  161. IDOLAZZI L, Adami S, Capozza R, Bianchi G, et al
    Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study.
    Clin Exp Rheumatol. 2015;33:895-9.
    PubMed     Text format     Abstract available


  162. MILUTINOVIC S, Radunovic G, Veljkovic K, Zlatanovic M, et al
    Development of ultrasound enthesitis score to identify patients with enthesitis having spondyloarthritis: prospective, double-blinded, controlled study.
    Clin Exp Rheumatol. 2015;33:812-7.
    PubMed     Text format     Abstract available


  163. BALCI MA, Pamuk ON, Pamuk GE, Uzundere FK, et al
    Epidemiology and outcome of adult-onset Still's disease in Northwestern Thrace region in Turkey.
    Clin Exp Rheumatol. 2015;33:818-23.
    PubMed     Text format     Abstract available


  164. CHEN SY, Shiau AL, Wu CL, Wang CR, et al
    Amelioration of experimental arthritis by intra-articular injection of an epidermal growth factor receptor tyrosine kinase inhibitor.
    Clin Exp Rheumatol. 2015;33:839-43.
    PubMed     Text format     Abstract available


    September 2015
  165. ATISHA-FREGOSO Y, Rivera-Vicencio Y, Banos-Pelaez M, Hernandez-Molina G, et al
    Main causes and risk factors for hospitalisation in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2015;33:721-5.
    PubMed     Text format     Abstract available


  166. UNGPRASERT P, Srivali N, Kittanamongkolchai W
    Risk of venous thromboembolism in patients with Sjogren's syndrome: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2015;33:746-50.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: